Introduction and Inspiration of Draft Guideline for Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics from the U.S. Food and Drug Administration

LI Zheng, YIN Maoshan, YIN Huajing, WANG Yin, WU Shuang, JIANG Kaidi, YU Bing, SUN Tao

Chinese Pharmaceutical Journal ›› 2025, Vol. 60 ›› Issue (24) : 2650-2657.

PDF(1247 KB)
PDF(1247 KB)
Chinese Pharmaceutical Journal ›› 2025, Vol. 60 ›› Issue (24) : 2650-2657. DOI: 10.11669/cpj.2025.24.012

Introduction and Inspiration of Draft Guideline for Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics from the U.S. Food and Drug Administration

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 60(24): 2650-2657 https://doi.org/10.11669/cpj.2025.24.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1247 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉